story of the week
Association Between Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
JAMA Neurol 2022 Jul 25;[EPub Ahead of Print], E Portaccio, M Fonderico, P Iaffaldano, L Pastò, L Razzolini, A Bellinvia, G De Luca, P Ragonese, F Patti, V Brescia Morra, E Cocco, P Sola, M Inglese, G Lus, C Pozzilli, D Maimone, A Lugaresi, P Gazzola, G Comi, I Pesci, D Spitaleri, M Rezzonico, M Vianello, C Avolio, FO Logullo, F Granella, M Salvetti, M Zaffaroni, G Lucisano, M Filippi, M Trojano, MP AmatoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.